欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/5108/002
药品名称Candesartan/Amlodipin TAD 16 mg/5 mg Tabletten
活性成分
    • amlodipine 5.0 mg
    • candesartancilexetil 16.0 mg
剂型Tablet
上市许可持有人TAD Pharma GmbH Heinz-Lohmann-Str. 5 27472 Cuxhaven Germany
参考成员国 - 产品名称Germany (DE)
Candesartan/Amlodipin TAD 16 mg/5 mg Tabletten
互认成员国 - 产品名称
    • Belgium (BE)
      Candesartan/Amlodipine Krka
    • Austria (AT)
      Candesartan/Amlodipin Krka 16 mg/5 mg Tabletten
    • Spain (ES)
    • Portugal (PT)
    • Finland (FI)
    • Poland (PL)
      Camlocor
    • Latvia (LV)
      Camlocor 16 mg/5 mg tabletes
    • Estonia (EE)
      Camdero
    • Bulgaria (BG)
    • Czechia (CZ)
      CAMDERO 16 MG/5 MG TABLETY
    • Romania (RO)
      Kandoset 16 mg/5 mg comprimate
    • Slovakia (SK)
    • Slovenia (SI)
      Camlocor 16 mg/5 mg tablete
许可日期2017/12/18
最近更新日期2024/03/27
药物ATC编码
    • C09DB07 candesartan and amlodipine
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Fixed combination Art 10b Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase